Catenae Innovation focused on commercialising Cov-ID app after positive
Catenae Innovation PLC’s (LON:CTEA) Guy Meyer caught up with Proactive London’s Andrew Scott after announcing its partner Newcastle Premier Health has successfully completed a proof-of-concept pilot trial of the Cov-ID app. Cov-ID is GDPR compliant identity documentation exchange system to record an individual’s coronavirus (COVID-19) test status through a mobile application.
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is…
In exchange for publishing services rendered by the Company on behalf of Catenae Innovation PLC named herein, including the promotion by the Company of Catenae Innovation PLC in any Content on the Site, the Company…
Read More: Catenae Innovation focused on commercialising Cov-ID app after positive